genprowebdirectory
Facebook Linkedin RSS Twitter Youtube
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Search
Facebook Linkedin RSS Twitter Youtube
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
  • News
    • Insights
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • Magazine
    • Browse Issues
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • GEN Live
    • Learning Labs
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
Home 2016

Biotie Therapies

Acorda Acquires Biotie Therapies for $363M
Industry News

Acorda Acquires Biotie Therapies for $363M

GEN Staff Writer -
January 19, 2016
0
Neurelis, Biotie Therapies Enter Option and Merger Agreement
Industry News

Neurelis, Biotie Therapies Enter Option and Merger Agreement

GEN Staff Writer -
June 4, 2013
0
Biotie Regains Asia-Pacific Rights for VAP-1 Antibody Program from Seikagaku
Drug Discovery

Biotie Regains Asia-Pacific Rights for VAP-1 Antibody Program from Seikagaku

GEN Staff Writer -
April 24, 2012
0
Biotie Axes Agreement to Acquire Newron on Latter’s Loss of Partner for Parkinson Disease Drug
Industry News

Biotie Axes Agreement to Acquire Newron on Latter’s Loss of Partner for Parkinson Disease Drug

GEN Staff Writer -
October 28, 2011
0
Biotie to Buy Newron in €45M Share-Based Deal
News

Biotie to Buy Newron in €45M Share-Based Deal

GEN Staff Writer -
September 27, 2011
0
Biotie to Acquire CNS Therapeutics Firm Synosia in €93.6M All-Shares Deal
Industry News

Biotie to Acquire CNS Therapeutics Firm Synosia in €93.6M All-Shares Deal

GEN Staff Writer -
January 11, 2011
0
Lundbeck and Biotie Report Alcohol Dependence Therapy Success in Two Phase III Studies
News

Lundbeck and Biotie Report Alcohol Dependence Therapy Success in Two Phase III Studies

GEN Staff Writer -
January 3, 2011
0
Biotie Restructures to Focus on Clinical Pipeline Headed by Lundbeck-Partnered Nalmefene
News

Biotie Restructures to Focus on Clinical Pipeline Headed by Lundbeck-Partnered Nalmefene

GEN Staff Writer -
October 29, 2010
0
Biotie to Take Over Elbion in Share-Exchange Transaction
News

Biotie to Take Over Elbion in Share-Exchange Transaction

GEN Staff Writer -
October 24, 2008
0

Read the Digital Edition

August 2023 cover

Explore

  • About GEN
  • Contact GEN
  • GEN Staff
  • Editorial Guidelines
  • Reprints and Permissions
  • Scientific Advisory Board

Advertise

  • Media Kit and Planning Calendar
  • Advertising Terms and Conditions

Resources

  • Get the GEN Magazine
  • Get the GEN Email Newsletter
  • Inside Precision Medicine
  • Privacy Policy
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
Scroll Up